+7 (495) 414-60-88 Moscow, st. 3rd Cherepkovskaya, 15A Driving directions About company Products Quality policy Publications Pharmacovigilance Vacancies Contacts Development and registration of a combination drug for the treatment of HIV infection based on nucleoside reverse transcriptase inhibitors (NRTIs) phosphazide and lamivudine The article discusses the development process of a combined drug Phosphaladin®, intended for the treatment of HIV infection, based on phosphazide and lamivudine. More details PHOSPHAZIDE IN THE TREATMENT OF COMBINED HIV INFECTION A literature review of the use of the antiretroviral drug Phosphazide (Nikavir) as a component of highly effective antiretroviral therapy, which was received by HIV-infected patients simultaneously infected with the hepatitis C virus, as well as patients with HIV infection and tuberculosis, was carried out. More details COMPLEX CHEMOTHERAPY OF PREGNANT WOMEN WITH HIV INFECTION A comparative study of the safety and efficacy of Nikavir (Phosphazide) and Combivir (Zidovudine + Lamivudine) in perinatal prophylaxis regimens in 96 HIV-infected mothers was carried out. More details POST-CONTACT CHEMIOPROPHYLAXIS OF HIV INFECTION A comparative assessment of the effectiveness of the use of various drug regimens for post-exposure prophylaxis of HIV / AIDS in 44 medical workers who had professional contact with HIV-infected patients was carried out. More details RETROSPECTIVE ANALYSIS OF THE APPLICATION OF THE DOMESTIC DRUG PHOSPHAZIDE IN HIV INFECTED PATIENTS WITH SEVERE IMMUNODEFICIENCY The efficacy and safety of HAART regimens containing phosphazide was studied in patients with a marked decrease in the number of CD4-β lymphocytes. For the treatment of HIV, phosphazide was prescribed to 567 patients, of which 236 patients were selected for statistical analysis. As a result of clinical use, phosphazide showed good immunological and virological activity. More details THREE-COMPONENT ART WITH PHOSPHAZIDE The aim of this study is to study the clinical efficacy of three-component antiretroviral therapy for HIV infection using phosphazide. More details 1 2 3 4 "You need to know" В даной статье перечисляются многие побочные эффекты современных нуклеозидных ингибиторов обратной транскриптазы ВИЧ. Никавир - препарат, который не уступает по эффективности зарубежным сотоварищам, но имеет несравнимо меньшее количество побочных эффектов. Наконец, опубликованы данные о применении Никавира (Фосфазида) в случае профилактики заражения ВИЧ-инфекцией медицинских работников, в научно практическом журнале "ВИЧ-инфекция и иммуносупресии" Фосфазид или Азидотимидин? В настоящее время в России стали выпускать дженерики, притом стали копировать препараты, от применения которых в западных странах отказались из-за их токсичности. Например, ставудин, который вызывает липодистрофию. © LLC "AZTpharma" , 2003-2016 The publication of materials from the site of LLC "AZTpharma" is allowed only if there is a link to the source. - Website development and promotion